|
Nasdaq II-VI Inc., down $2.35 at $16.25 The manufacturer cut its fiscal fourth-quarter outlook, citing the continued drop in prices of a key material it makes. Dyax Corp., down 18 cents at $1.96 The drug maker stopped a clinical trial of its angioedema drug Kalbitor because it did not work better than a placebo. AsiaInfo-Linkage Inc., up $1.71 at $12.79 Reuters reported that several private equity firms are interested in buying the Chinese telecommunications software provider.
Copyright 2012 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor